Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

KalVista Presents Additional Data On Its Phase 3 KONFIDENT Trial For Sebetralstat

Author: Benzinga Newsdesk | February 26, 2024 07:36am

The company 94% of attacks required only one dose to achieve primary endpoint, Further analyses demonstrate efficacy across all levels of attack severity and additional safety data reinforces flexibility of dosing.

Posted In: KALV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist